共 50 条
- [44] A phase I first-in-human study of the polo-like kinase 1-selective inhibitor, GSK461364, in patients with advanced solid tumors EJC SUPPLEMENTS, 2008, 6 (12): : 135 - 136
- [48] A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors Investigational New Drugs, 2016, 34 : 604 - 613